Emerging imaging tools and procedural techniques have refined the diagnosis and treatment of pleural diseases, including pleural effusion, empyema, pneumothorax, and malignant mesothelioma. Ultrasound-guided thoracentesis, pleural manometry, and indwelling pleural catheters are transforming patient care by reducing complications and enabling ambulatory management. Thoracoscopy remains a cornerstone for diagnosing unexplained effusions and administering talc pleurodesis. Pleural diseases research now focuses on molecular profiling of pleural fluid and minimally invasive biomarkers to improve diagnostic yield. Multidisciplinary input from pulmonologists, thoracic surgeons, and radiologists ensures accurate assessment and tailored treatment plans. Enhanced guidelines and procedural training are improving safety and outcomes across both inpatient and outpatient care environments.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation